Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">THR-317: Ph II started</h1><div class="byline">Chris Lieu</div><div class="date"></div></div></div></div>

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

Oxurion N.V.

ThromboGenics began a single-blind, European Phase II trial to evaluate 3 injections of 4 and 8 mg intravitreal THR-317 in about 50 patients.......

THR-317

Placental growth factor (PGF) (PLGF)

THR-317: Ph II started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

Bio€quity Europe

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Advertising - Sponsorship Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home